August 2020 – The publication describes the FDA’s regulatory path for approving new Sotalol IV dosing for a 1-day initiation or dose escalation. The data shows how a 1-hour Sotalol IV infusion can quickly reach therapeutic levels and thus, reduce hospital length of stay from 3 days down to 1 day.
May 2019 – Boston Strategic Group and AltaThera present hospital cost savings by using a 1-day initiation regimen. Over 7,200 patients in the Cerner electronic health record system who were admitted to the hospital for initiation of oral sotalol were analyzed. By reducing 3-day sotalol initiation to a 1-day procedure, the cost-saving per patient is $3,000; a significant reduction in hospital costs.